JAMA Health Forum Most Read
//www.igerbera.com/journals/jama-health-forum
The Most Read articles published by JAMA Health Forum
en-us
Sat, 29 Apr 2023 19:44:15 GMT
Sat, 29 Apr 2023 19:44:15 GMT
Silverchair
jamams@jamanetwork.org
support@www.igerbera.com
-
Inpatient Falls and Implementation of an Evidence-Based Fall Prevention Program
//www.igerbera.com/journals/jama-health-forum/fullarticle/2800748
Fri, 20 Jan 2023 00:00:00 GMT
This economic evaluation reports on the costs of inpatient falls and the cost savings associated with implementation of an evidence-based fall prevention program.
4
1
e225125
10.1001/jamahealthforum.2022.5125
2800748
-
Sex-Based Differences in Physician Hours and Income
//www.igerbera.com/journals/jama-health-forum/fullarticle/2802875
Fri, 24 Mar 2023 00:00:00 GMT
This cross-sectional study uses American Community Survey data to evaluate differences by sex in physician earnings and hours worked by age and family structure.
4
3
e230136
10.1001/jamahealthforum.2023.0136
2802875
-
Racial and Ethnic Differences in Barriers Faced by MCAT Examinees
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803727
Fri, 14 Apr 2023 00:00:00 GMT
这个横断面研究的医学大学承认ssion Test examinees assesses potential racial and ethnic barriers for those interested in a medical career and the association of these barriers with medical school application and matriculation.
4
4
e230498
10.1001/jamahealthforum.2023.0498
2803727
-
种族和毒理学测试尿液中怀孕的Patients During Labor and Delivery
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803729
Fri, 14 Apr 2023 00:00:00 GMT
This cohort study assesses the association of race with receipt of urine toxicology testing and a positive test result among pregnant patients admitted to the hospital for delivery.
4
4
e230441
10.1001/jamahealthforum.2023.0441
2803729
-
One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19
//www.igerbera.com/journals/jama-health-forum/fullarticle/2802095
Fri, 03 Mar 2023 00:00:00 GMT
This case-control study aims to quantify 1-year outcomes among individuals meeting a post–COVID-19 condition definition compared with a control group of individuals without COVID-19.
4
3
e230010
10.1001/jamahealthforum.2023.0010
2802095
-
Increasingly Privatized Public Health Insurance Programs in the US
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803380
Thu, 30 Mar 2023 00:00:00 GMT
This JAMA Forum discusses the increasingly privatized public health insurance programs in the US and the current debates over payment reform and prior authorization.
4
3
e231012
10.1001/jamahealthforum.2023.1012
2803380
-
Association of Primary Care Visit Length With Potentially Inappropriate Prescribing
//www.igerbera.com/journals/jama-health-forum/fullarticle/2802144
Fri, 10 Mar 2023 00:00:00 GMT
This cross-sectional study of a multistate sample of electronic health record data examines the association between primary care visit length and potentially inappropriate prescribing.
4
3
e230052
10.1001/jamahealthforum.2023.0052
2802144
-
The Case for Optimism in Health and Health Care
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803750
Thu, 06 Apr 2023 00:00:00 GMT
This JAMA Health Forum discusses challenges to the nation’s health and the case for optimism for better population health based on 3 pillars.
4
4
e231159
10.1001/jamahealthforum.2023.1159
2803750
-
Primary Care Practice Clinician Ownership and Quality Improvement Without Increasing Burnout
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803072
Fri, 31 Mar 2023 00:00:00 GMT
This cross-sectional study examines the factors associated with improving quality without increasing burnout among clinician- and non–clinician-owned primary care practices.
4
3
e230299
10.1001/jamahealthforum.2023.0299
2803072
-
Burnout, Professionalism, and the Quality of US Health Care
//www.igerbera.com/journals/jama-health-forum/fullarticle/2802872
Fri, 24 Mar 2023 00:00:00 GMT
This Viewpoint discusses the consequences of physician burnout and offers insights for its prevention.
4
3
e230024
10.1001/jamahealthforum.2023.0024
2802872
-
ALD Mortality by Race Before and During the COVID-19 Pandemic
//www.igerbera.com/journals/jama-health-forum/fullarticle/2804222
Fri, 21 Apr 2023 00:00:00 GMT
This cross-sectional study examines the national- and state-level age-adjusted mortality rates for alcohol-associated liver disease in 4 racial groups, with a focus on the American Indian or Alaska Native population.
4
4
e230527
10.1001/jamahealthforum.2023.0527
2804222
-
Estimated Use of Prescription Medications Among Individuals Incarcerated in the US
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803728
Fri, 14 Apr 2023 00:00:00 GMT
This cross-sectional study evaluates treatment with prescription medications in jails and state prisons relative to noncorrectional settings in the US.
4
4
e230482
10.1001/jamahealthforum.2023.0482
2803728
-
Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803504
Fri, 07 Apr 2023 00:00:00 GMT
This cross-sectional study uses data from a database to compare national trends in patients treated with buprenorphine by psychiatrists and nonpsychiatrists from 2003 to 2021.
4
4
e230221
10.1001/jamahealthforum.2023.0221
2803504
-
Association of OUD Treatment Pathway With Buprenorphine Initiation
//www.igerbera.com/journals/jama-health-forum/fullarticle/2802874
Fri, 24 Mar 2023 00:00:00 GMT
This cohort study evaluates the association between hospitals attesting to an opioid use disorder (OUD) emergency department (ED) treatment pathway and patients’ initiation of buprenorphine treatment.
4
3
e230245
10.1001/jamahealthforum.2023.0245
2802874
-
Association of Hardship Among Families With Young Children With Federal Relief Program Participation
//www.igerbera.com/journals/jama-health-forum/fullarticle/2804220
Fri, 21 Apr 2023 00:00:00 GMT
This cohort study of data from questionnaires administered before and during the COVID-19 crises to caregivers of children aged 48 months or younger examines the association of participation in COVID-19 relief programs with the mitigation of household food insecurity and being behind on rent as well as disparities in program participation among families with young children.
4
4
e230508
10.1001/jamahealthforum.2023.0508
2804220
-
Performance Measures and Visits at Federally Qualified Health Centers During the COVID-19 Pandemic
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803503
Fri, 07 Apr 2023 00:00:00 GMT
This cohort study examines changes in federally qualified health centers’ quality-of-care measures and visit volumes in 2020 to 2021 compared with before the COVID-19 pandemic.
4
4
e230351
10.1001/jamahealthforum.2023.0351
2803503
-
Timing of Confirmatory Trials for Drugs Granted Accelerated Approval Based on Surrogate Measures From 2012 to 2021
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803074
Fri, 31 Mar 2023 00:00:00 GMT
This cross-sectional study systematically characterizes the frequency of delayed confirmatory trials relative to deadlines set by the US Food and Drug Administration.
4
3
e230217
10.1001/jamahealthforum.2023.0217
2803074
-
Association Between Community-Level Social Risk and Spending Among Medicare Beneficiaries
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803073
Fri, 31 Mar 2023 00:00:00 GMT
This cross-sectional study examines the association between community-level social risk and health care spending among Medicare beneficiaries.
4
3
e230266
10.1001/jamahealthforum.2023.0266
2803073
-
When Abortion Is Illegal—Profound Effects on Resident Health and Well-being
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803500
Fri, 07 Apr 2023 00:00:00 GMT
This Viewpoint discusses the need for the leadership of hospital systems and graduate medical education programs to address the effects of abortion restrictions on medical residents’ health, well-being, and training.
4
4
e230275
10.1001/jamahealthforum.2023.0275
2803500
-
Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022
//www.igerbera.com/journals/jama-health-forum/fullarticle/2800864
Fri, 27 Jan 2023 00:00:00 GMT
This cross-sectional study uses a policy simulation analysis to assess how much Medicare price negotiation would have reduced prescription drug spending if the Inflation Reduction Act of 2022 had been effective from 2018 to 2020.
4
1
e225218
10.1001/jamahealthforum.2022.5218
2800864
-
How Trusted Local Entry Points Are Key to Improving Community Health
//www.igerbera.com/journals/jama-health-forum/fullarticle/2804022
Thu, 13 Apr 2023 00:00:00 GMT
本JAMA论坛讨论合作tween health systems and social service organizations for improving individual and community health, and provides 3 examples of trusted entry points for collaboration in addition to ideas for creating and expanding local entry points.
4
4
e231335
10.1001/jamahealthforum.2023.1335
2804022
-
Projected COVID-19 Mortality Reduction From Paxlovid Rollout
//www.igerbera.com/journals/jama-health-forum/fullarticle/2802663
Fri, 17 Mar 2023 00:00:00 GMT
This decision analytical model study assesses projections of simulated effects of Paxlovid rollout on hospitalizations and mortality using 10 models.
4
3
e230046
10.1001/jamahealthforum.2023.0046
2802663
-
Racial and Ethnic Differences in Insurance After Job Loss During COVID-19
//www.igerbera.com/journals/jama-health-forum/fullarticle/2803075
Fri, 31 Mar 2023 00:00:00 GMT
This cohort study uses national survey data to assess the racial and ethnic differences in insurance coverage after job loss during the first year of the COVID-19 pandemic.
4
3
e230168
10.1001/jamahealthforum.2023.0168
2803075
-
Private Equity Acquisition of Physician Practices and Health Care Spending and Utilization
//www.igerbera.com/journals/jama-health-forum/fullarticle/2795946
Fri, 02 Sep 2022 00:00:00 GMT
This difference-in-differences study of private equity acquisition of physician practices examines changes in prices and utilization associated with acquisition.
3
9
e222886
10.1001/jamahealthforum.2022.2886
2795946
-
The Costs of Long COVID
//www.igerbera.com/journals/jama-health-forum/fullarticle/2792505
Thu, 12 May 2022 00:00:00 GMT
Health Policy
3
5
e221809
10.1001/jamahealthforum.2022.1809
2792505